WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
ICLR
ICON PLC
$314.72$137.85128.30%37.92x21.60x3.16x2.76x1.19x$1.17B4.51%$9.43B114.23$29.27B18.06
STRR
STAR EQUITY HOLDINGS INC
$0.88$22.88-96.15%0.55xN/A0.30x0.21x0.02x$3.23M23.52%$65.30M4.18-$1.39M-0.05
FONR
FONAR CORP
$15.24N/AN/A9.47xN/A0.94x0.62xN/A$12.77M13.23%$165.76M26.17$89.19M3.48
TMO
THERMO FISHER SCIENTIFIC INC
$595.30$366.2562.54%38.04x21.98x5.35x4.99x0.74x$7.65B3.36%$45.52B119.15$257.34B22.63
IDXX
IDEXX LABORATORIES INC
$543.45$84.40543.88%52.10x49.00x12.12x28.61x7.00x$796.79M1.76%$1.57B18.88$45.53B36.67
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$221.61$198.5611.61%25.92x15.27x2.77x3.14x0.51x$413.61M3.63%$3.64B70.78$14.17B14.13
ENZ
ENZO BIOCHEM INC
$1.09$23.75-95.41%1.63xN/A4.29x0.79x0.02x-$45.92M-83.39%$70.78M1.40$2.70M0.08
DGX
QUEST DIAGNOSTICS INC
$144.34$80.4079.52%19.17x16.37x1.73x2.49x1.29x$947.00M5.91%$6.43B57.95$20.91B12.28
MEDP
MEDPACE HOLDINGS INC
$393.30$56.17600.22%38.67x53.88x6.18x18.15x393.69x$473.34M3.90%$671.54M21.77$11.91B29.36
SHC
SOTERA HEALTH CO
$11.29$15.75-28.30%59.42x9.18x2.96x7.44x0.27x-$376.77M-11.83%$429.39M1.52$5.28B12.39
NEOG
NEOGEN CORP
$13.54$3.43294.98%677.00x21.49x3.16x0.93x1.43x-$12.98M-0.44%$3.15B14.53$3.66B19.40
LAB
STANDARD BIOTOOLS INC
$2.57N/AN/A-2.54xN/A5.96x1.66xN/A-$99.88M-13.23%$577.32M1.96$761.24M-9.96
A
AGILENT TECHNOLOGIES INC
$154.23$70.96117.35%36.55x25.66x6.71x7.30x1.13x$1.65B3.65%$6.19B21.12$46.00B27.22
QGEN
QIAGEN NV
$45.69$21.50112.47%31.12x18.31x5.28x2.84x1.19x$367.58M3.59%$3.60B16.08$11.22B16.50
DHR
DANAHER CORP
$265.80$151.7475.17%44.60x22.78x8.74x3.68x0.78x$5.57B2.83%$53.44B72.16$208.01B27.59
FLGT
FULGENT GENETICS INC
$22.11N/AN/A-3.97x-28.71x2.29x0.59xN/A$18.78M2.85%$1.13B37.96$607.36M-4.76
SERA
SERA PROGNOSTICS INC
$8.26N/AN/A-7.72xN/A1,376.67x4.17xN/A-$17.11M-6.43%$64.75M2.01$266.50M-8.25
CSTL
CASTLE BIOSCIENCES INC
$24.24N/AN/A-21.26x-11.17x2.66x1.66xN/A-$6.44M-0.97%$402.46M14.64$611.30M-34.22
EXAS
EXACT SCIENCES CORP
$50.38N/AN/A-38.17x-22.29x3.62x2.97xN/A-$20.46M-0.22%$3.13B17.18$11.50B351.09
NTRA
NATERA INC
$106.46N/AN/A-34.12x-33.80x10.64x16.46xN/A-$186.98M-1.45%$794.11M6.57$12.69B-40.69
PRE
PRENETICS GLOBAL LTD
$5.80N/AN/A-1.04xN/A3.26x0.34xN/A-$13.43M-18.97%$206.36M16.91$27.50M-0.50
RVTY
REVVITY INC
$110.23$91.7720.11%90.35x15.95x4.99x1.73x0.45x$97.11M0.71%$7.85B63.57$16.61B24.96
CHEK
CHECK-CAP LTD
$2.19N/AN/A-0.73x-0.91xN/A0.54xN/A-$17.04M-133.32%$23.69M4.05$3.94M-0.21
OLK
OLINK HOLDING AB (PUBL)
$23.95N/AN/A-88.70x479.00x17.43x6.45xN/A-$59.68M-2.00%$461.63M3.71$2.89B-135.63
LH
LABCORP HOLDINGS INC
$210.59$230.88-8.79%41.29x10.54x1.44x2.23x0.36x$683.20M3.85%$7.96B94.43$23.62B15.21
WAT
WATERS CORP
$355.95$172.59106.25%34.86x24.41x7.25x16.80x1.07x$514.03M2.44%$1.26B21.21$22.92B23.40
PRPO
PRECIPIO INC
$6.29N/AN/A-1.84xN/A0.57x0.72xN/A-$2.76M-30.72%$12.77M8.96$9.40M-2.79
DRIO
DARIOHEALTH CORP
$1.90N/AN/A-1.13x-0.98x3.44x0.73xN/A-$39.30M-60.05%$78.03M2.27$52.92M-1.05
NEO
NEOGENOMICS INC
$14.80N/AN/A-22.42x-29.60x3.06x2.05xN/A-$39.59M-2.12%$923.41M7.32$2.17B1,633.79
TWST
TWIST BIOSCIENCE CORP
$47.01N/AN/A-13.99x-12.57x9.79x4.89xN/A-$95.52M-3.52%$560.13M9.69$2.58B-16.63
IQV
IQVIA HOLDINGS INC
$231.18$118.6394.88%31.16x19.04x2.79x6.64x1.04x$1.62B3.86%$6.34B34.88$54.42B16.65
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,522.75$539.24182.39%42.48x31.48x8.62x-204.91x1.56x$903.92M2.77%-$158.72M-7.40$34.54B29.57
BNR
BURNING ROCK BIOTECH LTD
$8.30N/AN/A-0.94x-1.09x1.14x0.80xN/A-$36.49M-42.93%$106.28M10.38$1.64M-0.02
ACRS
ACLARIS THERAPEUTICS INC
$1.19N/AN/A-1.09x-0.75x2.72x0.60xN/A-$73.68M-87.14%$142.01M2.00$48.96M-0.64
RDNT
RADNET INC
$57.45$6.88735.36%174.09x108.40x2.40x4.86x3.97x$27.32M0.69%$872.96M12.60$5.24B18.63
CDNA
CAREDX INC
$15.50N/AN/A-4.55x-29.25x2.91x3.15xN/A-$41.43M-5.17%$256.23M4.96$740.31M-4.23
PSNL
PERSONALIS INC
$1.40N/AN/A-0.74x-0.64x0.96x0.60xN/A-$68.16M-96.07%$120.69M2.38$66.17M-0.83
STIM
NEURONETICS INC
$2.61N/AN/A-2.75x-3.03x1.05x2.83xN/A-$31.35M-40.77%$27.66M0.94$93.04M-4.77
ME
23ANDME HOLDING CO
$0.59N/AN/A-0.53xN/A1.14x0.75xN/A-$194.26M-68.82%$377.19M0.78$118.48M-0.24
GH
GUARDANT HEALTH INC
$25.36N/AN/A-6.40x-5.02x5.11x45.45xN/A-$300.71M-9.74%$68.29M0.56$3.29B-7.95
XWEL
XWELL INC
$1.74N/AN/A-0.29xN/A0.23x0.69xN/A-$14.68M-201.72%$10.57M2.53$14.32M-0.66
OCX
ONCOCYTE CORP
$2.93N/AN/A-0.58x1.05x17.54x3.38xN/A-$17.43M-72.01%$11.59M1.40$35.22M-0.91
MYGN
MYRIAD GENETICS INC
$25.29N/AN/A-9.03xN/A2.94x3.01xN/A-$154.70M-6.81%$760.00M8.45$2.34B-14.29
DMTK
DERMTECH INC
$0.50N/AN/A-0.19x-0.15x1.11x0.44xN/A-$72.22M-417.03%$39.99M1.15$40.07M-0.48
XGN
EXAGEN INC
$1.88N/AN/A-1.72x-1.39x0.61x1.63xN/A-$14.25M-42.23%$19.99M1.11$28.43M-2.02
PRPH
PROPHASE LABS INC
$5.03N/AN/A-3.70x6.45x3.16x2.14xN/A-$20.47M-22.56%$44.87M2.49$117.57M-5.00
AWH
ASPIRA WOMEN's HEALTH INC
$2.66N/AN/A-1.87x-0.43x3.50x-24.30xN/A-$14.66M-46.50%-$1.36M-0.12$32.13M-2.20
NDRA
ENDRA LIFE SCIENCES INC
$0.31N/AN/A-0.27xN/AN/A0.92xN/A-$9.21M-277.52%$3.70M0.34$2.58M-0.27
VNRX
VOLITIONRX LTD
$0.77N/AN/A-1.67xN/A77.00x-4.09xN/A-$18.57M-29.48%-$15.61M-0.19$57.54M-1.73
MDXH
MDXHEALTH SA
$2.88N/AN/A-0.21x-2.27x0.10x-8.08xN/A-$24.92M-317.15%-$973.00k-0.36$101.07M-4.72
GENE
GENETIC TECHNOLOGIES LTD
$2.28N/AN/A-0.77xN/A0.08x0.17xN/A-$5.00M-1,139.39%$3.15M16.35-$1.66MN/A
NOTV
INOTIV INC
$1.93N/AN/A-0.70xN/A0.09x0.24xN/A$14.38M28.86%$207.16M8.02$446.69M23.11
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.26N/AN/A-2.46xN/A4.54x5.01xN/A-$6.89M-30.75%$5.26M0.53$25.39M-3.21
MYNZ
MAINZ BIOMED NV
$0.68N/AN/A-0.42xN/A12.36x4.43xN/A-$23.84M-215.88%$3.25M0.20$13.71M-0.56
ILMN
ILLUMINA INC
$111.07N/AN/A-13.63x19.12x3.93x3.09xN/A$366.00M2.07%$5.73B36.06$18.78B-29.34
OPK
OPKO HEALTH INC
$1.32N/AN/A-3.77x-11.00x1.17x0.73xN/A-$56.36M-6.06%$1.25B1.77$1.25B-9.78
PMD
PSYCHEMEDICS CORP
$2.58N/AN/A-3.35xN/A0.69x2.38xN/A-$1.85M-12.36%$6.28M1.08$15.52M-16.00
APDN
APPLIED DNA SCIENCES INC
$2.51N/AN/A-0.15x0.04x0.40x-51.33xN/A-$11.06M-505.50%-$48.15k-0.06-$433.86k0.04
TRIB
TRINITY BIOTECH PLC
$1.58N/AN/A-0.49xN/A0.21x-0.51xN/A-$14.57M-120.32%-$23.95M-3.12$75.85M-6.74
BDSX
BIODESIX INC
$1.58N/AN/A-2.92x-3.42x2.79x-32.83xN/A-$46.12M-30.16%-$5.50M-0.06$230.31M-7.17
MMA
ALTA GLOBAL GROUP LTD
$4.54N/AN/A-0.86xN/A30.29xN/AN/A-$5.92M-12.74%-$69.50M-6.80N/AN/A
ISPC
ISPECIMEN INC
$0.24N/AN/A-0.19xN/A0.24x0.35xN/A-$8.54M-387.97%$6.81M0.75$471.74k-0.05
TTOO
T2 BIOSYSTEMS INC
$5.64N/AN/A-0.49xN/A4.01x-1.31xN/A-$46.95M-163.39%-$37.77M-7.41$92.33M-2.39
CNTG
CENTOGENE NV
$0.37N/AN/A-0.27xN/A0.20x-0.38xN/A-$34.08M-333.78%-$27.18M-0.99$76.06M-3.63

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 47, which is 21 points higher than the diagnostic & research industry average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 49.4% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 9.42% from Icon's current stock price of $314.72.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second best diagnostic & research stock with a Zen Score of 46, which is 20 points higher than the diagnostic & research industry average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 10% over the past year, underperforming other diagnostic & research stocks by -1 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third best diagnostic & research stock with a Zen Score of 43, which is 17 points higher than the diagnostic & research industry average of 26. It passed 13 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock lose -9.98% over the past year, underperforming other diagnostic & research stocks by -21 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.8%, which is 2 percentage points higher than the diagnostic & research industry average of 1.25%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2%, which is 1 percentage points higher than the diagnostic & research industry average of 1.25%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Labcorp Holdings (NYSE:LH)


Labcorp Holdings (NYSE:LH) has an annual dividend yield of 1.03%, which is the same as the diagnostic & research industry average of 1.25%. Labcorp Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Labcorp Holdings's dividend has not shown consistent growth over the last 10 years.

Labcorp Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.44% in the last day, and up 1.56% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 10% in the past year. It has underperformed other stocks in the diagnostic & research industry by -1 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -52.81% in the past year. It has underperformed other stocks in the diagnostic & research industry by -64 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has dropped -9.98% in the past year. It has underperformed other stocks in the diagnostic & research industry by -21 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 5.02% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.96x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.